Cargando…
Innate Immune Responses to AAV Vectors
Gene replacement therapy by in vivo delivery of adeno-associated virus (AAV) is attractive as a potential treatment for a variety of genetic disorders. However, while AAV has been used successfully in many models, other experiments in clinical trials and in animal models have been hampered by undesi...
Autores principales: | Rogers, Geoffrey L., Martino, Ashley T., Aslanidi, George V., Jayandharan, Giridhara R., Srivastava, Arun, Herzog, Roland W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175613/ https://www.ncbi.nlm.nih.gov/pubmed/21954398 http://dx.doi.org/10.3389/fmicb.2011.00194 |
Ejemplares similares
-
Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B
por: Rogers, Geoffrey L, et al.
Publicado: (2014) -
High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo
por: Song, Liujiang, et al.
Publicado: (2013) -
Improved ocular gene transfer with a Neddylation-site modified AAV-RPE65 vector in rd12 mice
por: Maurya, Shubham, et al.
Publicado: (2020) -
Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
por: Sen, Dwaipayan, et al.
Publicado: (2013) -
Optimized AAV rh.10 Vectors That Partially Evade Neutralizing Antibodies during Hepatic Gene Transfer
por: Selot, Ruchita, et al.
Publicado: (2017)